Xuean Mo
#6 Shuangyong Road
Nanning, 530021, China
Nanning, 530021, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
FcRn inhibition with efgartigimod ameliorates muscle weakness and modulates dendritic cell subsets in an experimental autoimmune myasthenia gravis mouse model.
Journal: International immunopharmacology
Published: May 05, 2025
The P38MAPK Pathway Mediates the Destruction of the Blood-Brain Barrier in Anti-NMDAR Encephalitis Mice.
Journal: Neurochemical research
Published: March 13, 2024
Clinical Characteristics of Myasthenia Gravis Patients with COVID-19 in Guangxi, China: A Case-Control Study.
Journal: Journal of inflammation research
Published: April 29, 2023
Inhibiting PI3K/Akt-Signaling Pathway Improves Neurobehavior Changes in Anti-NMDAR Encephalitis Mice by Ameliorating Blood-Brain Barrier Disruption and Neuronal Damage.
Journal: Cellular and molecular neurobiology
Published: March 11, 2023
miR-548k regulates CXCL13 expression in myasthenia gravis patients with thymic hyperplasia and in Jurkat cells.
Journal: Journal of neuroimmunology
Published: June 25, 2017
Mutation analysis of presenilin 1 gene in a Chinese family affected with early-onset familial Alzheimer's disease
Journal: Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
Published: June 07, 2016
Altered expression of miR-125a-5p in thymoma-associated myasthenia gravis and its down-regulation of foxp3 expression in Jurkat cells.
Journal: Immunology letters
Published: September 06, 2015
Rosiglitazone suppresses HIV-1 Tat-induced vascular inflammation via Akt signaling.
Journal: Molecular and cellular biochemistry
Published: March 16, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026